Comparison

Recombinant Mouse SFTPD/SP-D Protein (His Tag)

Item no. ELS-PKSM040805-100ug
Manufacturer Elabscience
Amount 100 ug
Quantity options 100 ug 50 ug
Category
Type Proteins
Format Lyophilized Powder
Specific against Mouse (Murine, Mus musculus)
Host HEK293 cells
Conjugate/Tag HIS
Purity > 97 % as determined by reducing SDS-PAGE.
Sequence Met 1-Phe 374
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias COLEC7, Collectin 7, Lung surfactant protein D, PSPD, Pulmonary surfactant-associated protein D, SFTP4, SFTPD, SP-D, SP-Dpulmonary surfactant apoprotein, SPD, pulmonary-associated protein D, surfactant, surfactant protein D
Similar products SFTPD, COLEC7, PSPD, SFTP4, Pulmonary surfactant-associated protein D, Lung surfactant protein D, SPD, surfactant, SP-D, pulmonary-associated protein D, Collectin 7, SP-Dpulmonary surfactant apoprotein, surfactant protein D
Shipping Condition Cool pack
Available
Manufacturer - Category
Recombinant Proteins / Others
Manufacturer - Conjugate / Tag
C-His
Shipping Temperature
This product is provided as lyophilized powder which is shipped with ice packs.
Storage Conditions
Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
Calculated Molecular Weight
37.2 kDa
Observed Molecular Weight
45 kDa
Background
Surfactant pulmonary-associated protein D, also known as SFTPD and SP-D, is a member of the collectin family of C-type lectins that is synthesized in many tissues including respiratory epithelial cells in the lung, and contains one C-type lectin domain and one collagen-like domain. The polymorphic variation in the N-terminal domain of the SP-D molecule influences oligomerization, function, and the concentration of the molecule in serum. SFTPD is produced primarily by alveolar type II cells and nonciliated bronchiolar cells in the lung and is constitutively secreted into the alveoli where it influences surfactant homeostasis, effector cell functions, and host defense. It is upregulated in a variety of inflammatory and infectious conditions including Pneumocystis pneumonia and asthma. SFTPD is humoral molecules of the innate immune system, and is considered a functional candidate in chronic periodontitis. Besides it is involved in the development of acute and chronic inflammation of the lung. Several human lung diseases are characterized by decreased levels of bronchoalveolar SFTPD. Thus, recombinant SFTPD has been proposed as a therapeutical option for cystic fibrosis, neonatal lung disease and smoking-induced emphysema. Furthermore, SFTPD serum levels can be used as disease activity markers for interstitial lung diseases.
Endotoxin
< 1.0 EU per μg of the protein as determined by the LAL method.
Reconstitution
Please refer to the printed manual for detailed information.
Formulation
Lyophilized from sterile PBS, pH 7.4
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Activity
Not validated for activity

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?